History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: Experience from the largest women's hospital in China-Reference-Cited by-同舟云学术

History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: Experience from the largest women's hospital in China

Published:2015-05-08 Issue:7 Volume:123 Page:421-427
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Tao Xiang¹,Griffith Christopher C.²,Zhou Xiangrong¹,Wang Zhiheng¹,Yan Yabin¹,Li Zaibo³,Zhao Chengquan²

Affiliation:

1. Department of Pathology; Obstetrics and Gynecology Hospital of Fudan University; Shanghai China

2. Department of Pathology; Magee-Womens Hospital of UPMC; University of Pittsburgh Medical Center; Pittsburgh Pennsylvania

3. Department of Pathology; Ohio State University Wexner Medical Center; Columbus Ohio

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncy.21545/fullpdf

Reference25 articles.

1. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy;Koss;JAMA,1989

2. International incidence rates of invasive cervical cancer after introduction of cytological screening;Gustafsson;Cancer Causes Control,1997

3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide;Walboomers;J Pathol,1999

4. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice;Katki;Lancet Oncol,2011

5. Human papillomavirus and Papanicolaou tests to screen for cervical cancer;Naucler;N Engl J Med,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective analysis of cytology and high‐risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions;Cancer Cytopathology;2024-02-19

2. The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer;Apoptosis;2022-08-18

3. The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer;International Journal of Gynecological Pathology;2022-04-12

4. Risk stratification for cervical neoplasia using extended high‐risk HPV genotyping in women with ASC‐US cytology: A large retrospective study from China;Cancer Cytopathology;2021-12-07

5. Emerging technologies for cervical cancer screening;Japanese Journal of Clinical Oncology;2021-07-09